BMC Neurology

BMC Neurology is an open access journal published by BioMed Central, part of Springer Nature, and founded in 2001, covering the prevention, diagnosis and treatment of neurological disorders, with a 2024 impact factor of 2.2（BMC Neurology）是 BioMed Central（现属 Springer Nature）出版的开放获取期刊，2001 年创刊，刊载神经系统疾病的预防、诊断与治疗研究，2024 年影响因子为 2.2。

Scope

• Neurodegenerative diseases, cerebrovascular disease, epilepsy and seizure disorders神经退行性疾病、脑血管病、癫痫与发作性疾病。
• Headache and migraine, neuroimmunology and autoimmune diseases, neuromuscular disorders and movement disorders头痛与偏头痛、神经免疫与自身免疫病、神经肌肉疾病与运动障碍。
• Cognitive and behavioural neurology and infectious diseases of the nervous system认知与行为神经病学，以及神经系统感染性疾病。
• The genetic and molecular basis of neurological disorders, clinical trials and therapeutic interventions神经系统疾病的遗传与分子基础、临床试验与治疗干预。
• Neuroepidemiology and population studies, diagnostic biomarkers and neuroimaging神经流行病学与人群研究、诊断生物标志物与神经影像。
• Prevention strategies and public health approaches in neurology神经病学的预防策略与公共卫生路径。
• Article types include Research Articles, Database Articles, Software Articles, Case Reports, Study Protocols, Reviews, Systematic Reviews, Matters Arising and Short Reports文章类型包括研究论文、数据库论文、软件论文、病例报告、研究方案、综述、系统综述、来函澄清与短报告。

History

• Founded in 2001 by BioMed Central, which was established in 2000 as the world's first commercial open access publisher该刊 2001 年由 BioMed Central 创办，该社成立于 2000 年，是全球首家商业开放获取出版商。
• It has been fully open access since its foundation, with articles published under Creative Commons attribution or attribution non-commercial no-derivatives licences and copyright retained by the authors该刊自创刊起即为完全开放获取，文章以知识共享署名或署名非商业性禁演绎许可发布，版权由作者保留。
• BioMed Central was acquired by Springer Science+Business Media in October 20082008 年十月，BioMed Central 被施普林格科学与商业媒体收购。
• Springer and Nature Publishing Group merged in 2015 to form Springer Nature, under which the publisher now operates2015 年，施普林格与自然出版集团合并组建施普林格·自然，该社现归其旗下。
• Articles are added consecutively to the current annual volume and the journal is electronic only文章按篇连续累积入当年卷，仅出电子版。
• Its impact factor was 2.2 in 2024, with a five year impact factor of 2.5该刊 2024 年影响因子为 2.2，五年影响因子为 2.5。

Editors

• The lead editor is Dimitra Mazaraki, based in the Berlin office of Springer Nature and with a background in neuroscience and sensory physiology现任 Lead Editor 为 Dimitra Mazaraki，任职于施普林格·自然柏林办公室，具神经科学与感觉生理学背景。
• There are assistant editors and thirteen associate editors, together with senior and ordinary editorial board members该刊设助理编辑与十三名副编辑，另有资深编委与普通编委。
• Board members come from many countries and include Harry Alexopoulos of the University of Athens, Anna Bersano of Milan and Jens Schmidt of the University of Göttingen编委来自数十个国家，包括雅典大学的 Harry Alexopoulos、米兰的 Anna Bersano 与哥廷根大学的 Jens Schmidt。
• The journal uses transparent peer review, in which the referee reports are published alongside accepted articles under a Creative Commons licence while the referees remain anonymous该刊采用透明评审，文章录用后评审报告以知识共享许可随文公开，但审稿人保持匿名。
• Manuscripts are usually assessed by at least two reviewers, and the editor makes the decision and may consult board members稿件通常由两名以上审稿人评审，由编辑作出决定并可咨询编委。
• In line with the BioMed Central series, the journal does not accept or reject papers on perceived interest or potential impact but only requires that the research be scientifically valid作为该社系列期刊，该刊不以感知兴趣或潜在影响取舍稿件，只要求研究在科学上成立。